The Biden-Harris administration proposed a new rule Tuesday to cover the cost of weight-loss drugs like Ozempic, Wegovy and Mounjaro for millions of Americans.
Read More
Last Thursday, Robert F. Kennedy, Jr. withdrew (kind of) from the 2024 presidential race. He didn’t have to, and in the case of 40 out of 50 states, he actually didn’t. But, he also didn’t have to endorse Donald J. Trump, and yet he did. As I waited for his press conference, I wondered: What could drive a lion of Democratic party royalty to side with Trump? The answer turned out to be a trio of existential crises. As RFK Jr. explained, he and Trump are aligned on three critical issues, and they are of such existential importance that he was willing to set aside their differences to work together.
Beyond being a refreshing break from the mind-numbing drumbeat of Trump’s opposition, RFK Jr.’s remarks were a stark reminder of why two-thirds of Americans believe the country is moving down the wrong track. He first took aim at the military-industrial complex’s perpetual provoking of foreign wars and followed up with the alarming assault on free speech. These were, however, just the warmup acts for his primary grievance: the moral and legal corruption of the food and pharmaceutical industries, assisted by their captured agencies, e.g., the FDA and USDA.
Read More
In Tennessee, the battle to protect pharmacy benefits is not merely a matter of policy, but a battle to protect our country from unnecessary government overreach by the extreme Left. I am deeply troubled by recent attempts at the federal level that target pharmacy benefits and our free market – all in one swoop.
People across our state are already experiencing immense financial strain as they grapple with the soaring costs of inflation and prescriptions, and we need to advocate for policies that will effectively lower these prices through free market competition.
Read More
Big Pharma is not your friend. Whether it’s hiking up drug prices or bribing the Swamp, the pharmaceutical industry works against the people’s interests. Many Americans are aware of Big Pharma’s greed and the power it wields over Washington, D.C., but fewer are aware of just how left-wing the industry is. It serves as a cash cow for the left and pushes woke ideas on its employees and the country at large. This may explain why Democrats, who act like they hate Big Pharma, serve the industry’s interests.
While the drugmakers spread their cash around all of DC, they overwhelmingly prefer Democrats. In recent elections, Big Pharma donated significantly more money to Democratic candidates than Republican candidates. From 2016 to 2022, the industry gave a whopping $29 million to Democratic candidates. This trend stands true for the current election cycle, with more cash going to Democrats once again. This favoritism extends to the presidential race. The drug lobby has donated four times more money to Joe Biden than it has to Donald Trump. And the industry’s generosity to Team Blue doesn’t end with individual candidates. Its chief lobby, PhRMA, also gives millions to liberal campaign arms like the Democratic Attorneys General Association.
Read More